Pfizer, Astellas revise two cancer drug trial protocols to speed up results
Drugmakers Pfizer Inc and Astellas Pharma Inc said on Wednesday they would change protocols for two late-stage trials testing prostate cancer drug Xtandi to speed up completion.
from Reuters: Health News https://reut.rs/2w5FogC
http://bit.ly/2zwRqiM